The number of people with susceptibility test result for rifampicin in Panama
Panama: The number of people with susceptibility test result for rifampicin was 497 in 2021. ▲ Rising
Latest (2021)
497
Change on year
up 21.8%
World rank
79th
of 155 countries
All-time high
583
in 2018
All-time low
322
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Panama, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Panama recorded 497 for the number of people with susceptibility test result for rifampicin in 2021.
Compared with earlier readings it is up 21.8% on the previous year and up 54.3% over five years.
That places Panama 79th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Panama, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 322 | — |
| 2018 | 583 | +81.1% |
| 2019 | 526 | -9.8% |
| 2020 | 408 | -22.4% |
| 2021 | 497 | +21.8% |
Panama compared with similar countries
- Panama's 497 is above the median for high income countries, which is 142, 3.5× the median. (61 countries reporting)
- Panama's 497 is above the median for Latin America & Caribbean, which is 406.5, 1.2× the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 477 | 322 | 583 | 3 |
| 2020s | 452.5 | 408 | 497 | 2 |
Countries ranked near Panama
More health data for Panama
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5994 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,074 deaths per 1,000 people (2090)
- Number of infants who die before age 1 101 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate -0.2522 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0378 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3451 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Panama?
- The number of people with susceptibility test result for rifampicin in Panama was 497 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Panama?
- The highest recorded value was 583 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Panama?
- The lowest recorded value was 322 in 2017.
- How does Panama rank for the number of people with susceptibility test result for rifampicin?
- Panama ranks 79th out of 155 countries with data for 2021.
- Where does this Panama data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).